Invus Global Management, LLC bought $2.0M of Lexicon Pharmaceuticals (LXRX)

Executed Feb 2, disclosed Feb 4, 2 days later.

Value, as filed

$2.0M

1,538,462 sh × $1.30

Executed

Feb 2

the trade date, as filed

Disclosed

Feb 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+27.1%

+40.0% from execution

Over the 21 trading sessions from the disclosed entry session (Feb 4), the stock returned +27.1% (delay-adjusted); from the execution session (Feb 2), +40.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

IL Invus Global Management, LLC Director profile →

Invus Global Management, LLC (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in LXRX. Across 1 priced purchase filing, the average 21-session return was +40.0% from execution and +27.1% from disclosure (delay-adjusted; derived). The largest single filing was $2.0M of LXRX (1,538,462 sh × $1.30, as filed), executed Feb 2.

The name

LXRX LXRX LXRX · 4 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→